For More Information:

LAW For More Information: Kimberly Goolsby (949) 464-0187 Kimberly@GoolsbyGroup.com FOR IMMEDIATE RELEASE FDA APPROVES REFRACTECs® CKSM (Conductive KeratoplastySM) NON-LASER PROCEDURE FOR FARSIGHTEDNESS CK Uses Radiofrequency Energy, Instead of a Laser, to Reshape the Cornea Without stabbing or Removing Tissue IRVINE, Calif., April 16, 2002 Ophthalmic device manufacturer Refractec Inc. promptly announced that the U.S. Food and Drug Administration has approved CK (Conductive Keratoplasty), a procedure for farsightedness (hyperopia) in people over depot 40.

CK utilizes the controlled release of radiofrequency (RF) energy, instead of a laser or sca lpel, to desexualize the cornea. The minimally invasive CK procedure takes less than three transactions and is done in-office with only topical (eye drop) anesthesia. Farsightedness, which occurs when the cornea is too flat or the eye is too short, is the most common vision roughness in America and affects more than 60 million ...If you have to get a full essay, order it on our website: OrderEssay.net

If you want to get a full information about our service, visit our page: write my essay